- The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
The result of the debate was delete. --Pablo D. Flores (Talk) 18:44, 23 March 2006 (UTC)[reply]
Hi - this is a non-notable subject that has remained a one-liner and unsourced for nearly 6 months. Rama's Arrow 04:24, 17 March 2006 (UTC)[reply]
Delete per nom. Rama's Arrow 04:24, 17 March 2006 (UTC)[reply]
- Redirect and merge to Himalaya Drugs, the company he's CEO of, which might be borderline notable under WP:CORP. Sandstein 05:36, 17 March 2006 (UTC)[reply]
- Delete per nom... redirect to non-article that may or may not meet WP:CORP doesn't seem like the right solution.--Isotope23 17:05, 17 March 2006 (UTC)[reply]
- Delete per nom. mikka (t) 23:34, 17 March 2006 (UTC)[reply]
- Redirect and merge to Himalaya Drugs, it meets the first stipulation of WP:CORP definitely. --Gurubrahma 10:29, 18 March 2006 (UTC)[reply]
- Redirect per Gurubrahma. Walter Siegmund (talk) 04:35, 21 March 2006 (UTC)[reply]
- Closing comment: You can't redirect to a non-existant article. If the company is in fact notable, I suggest somebody write an article about it and mention Mr. Prasad there. --Pablo D. Flores (Talk) 18:44, 23 March 2006 (UTC)[reply]
- The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.